Public View of Electronically Registered Products
Certificates issued on 26-Aug-2020
Electronically Registered Product Details
Electronically Registered Product Details
# | Local Technical Representative | Application Number | Product Trade Name | Human Vet | Local Foreign | Inn Of Api | Api Strength Per Dosage | Product Registration No | Dosage Form Name | Routes Name | Evaluated | Shelf Life Name | Product Visual Desc | Atc Code Name | Pharmacotherapeutic Group | Mah Company Name | Mah Company Address | Mah Company Email | Site Name | Site Address | Status Name | Status Description |
1 | PHILLIPS HEALTHCARE SERVICES LTD | 16504 | Dolutegravir (as sodium) , Lamivudine and
| Human | Foreign | Dolutegravir (as sodium) , Lamivudine and
| Dolutegravir (as sodium): 50 mg , Lamivudine: 300
| H2020/CTD7980/16504 | Film-Coated Tablet | ORAL | Recommended | 24 months | Blue coloured, capsule shaped biconvex film
| J05AR12 | lamivudine and tenofovir disoproxil | Cipla Limited | Cipla House, Peninsula Business Park, Ganpatrao
| globalra@cipla.com | Cipla Limited Goa Unit VII | | Registered | Valid |